Yolk Sac Tumors of the Head and Neck in Aicardi Syndrome

Ann Otol Rhinol Laryngol. 2020 Mar;129(3):301-305. doi: 10.1177/0003489419883660. Epub 2019 Oct 22.

Abstract

Objectives: To understand that yolk sac tumors (YSTs) of the head and neck (H&N) are exceedingly rare and typically carry a poor prognosis. To acknowledge the possibility of increased incidence in patients with Aicardi Syndrome and the ramifications this has on early diagnosis and treatment in this population.

Methods: To date, four germ cells tumors of the H&N have been reported in patients with Aicardi Syndrome. This report presents the second known case of a H&N YST in a patient with Aicardi syndrome. In both cases, the patient was initially misdiagnosed given unconvincing radiologic evidence. However, tissue diagnosis and elevated alpha-fetoprotein (AFP) levels were suggestive of a YST.

Results: In contrast to the poor prognosis previously described, both patients with Aicardi syndrome had an excellent chemotherapeutic response exhibited by normalization of AFP levels and imaging.

Conclusions: Rare germ cell tumors of the H&N, such as YSTs, have now been documented in several patients with Aicardi syndrome, indicating a possible association given the rarity of these tumors in the population. YSTs should be considered in the differential diagnosis of H&N masses in these patients, with emphasis on early tissue diagnosis and treatment.

Keywords: aicardi syndrome; biopsy; differential diagnosis; endodermal sinus tumor; yolk sac.

Publication types

  • Case Reports

MeSH terms

  • Aicardi Syndrome / complications*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Endodermal Sinus Tumor / diagnostic imaging*
  • Endodermal Sinus Tumor / drug therapy
  • Female
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / drug therapy
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Tomography, X-Ray Computed
  • alpha-Fetoproteins / analysis

Substances

  • alpha-Fetoproteins